Recombinant DMA Advisory Committee - 5/30-31/91 
Executive secretaiy: 
Nelson A. Wivel, National Institutes of Health 
A committee roster is attached (Attachment). 
Ad hoc consultant: 
LeRoy Walters, Georgetown University 
Non-voting agency representatives: 
Daniel P. Jones, National Endowment for the Humanities 
Henry I. Miller, Food and Drug Administration 
Sue A. Tolin, U.S. Department of Agriculture 
National Institutes of Health staff: 
W. French Anderson, NHLBI 
Jan Casadei, NCI 
MaryEllen Franko, NCI 
Christine Ireland, OD 
Becky Lawson, OD 
Debbie Wilson, OD 
Others: 
Paul Aebersold, Food and Drug Administration 
M. James Barrett, Genetic Therapy, Inc. 
Arindam Bose, Pfizer, Inc. 
Malcolm Brenner, St. Jude Childrens Hospital 
Yawen Chiang, Genetic Therapy, Inc. 
Thomas Copmann, Pharmaceutical Manufacturers Association 
Albert Deisseroth, MD Anderson Cancer Center 
Sharon Durfy, Kennedy Institute 
George Ferry, Baylor College of Medicine 
Diane Reming, Merck & Co. 
Jeffrey Fox, Science Writer 
Robert Goldberg, Merck & Co. 
MaryAnn Grossman, University of Michigan 
Winifred Hodge, University of Illinois 
John Jaugstetter, Genentech, Inc. 
Dorothy Jessop, U.S. Department of Agriculture 
Daniel Kuebbing, Genetic Therapy, Inc. 
[608] 
Recombinant DNA Research, Volume 14 
